NIH-funded research R21 grant

Single-cell view of lung macrophage roles in TB lesions

Official title: Single-cell spatial-temporal understanding of the role of macrophage subsets in maintenance of lesion biology and local Mycobacterium tuberculosis infection outcome.

Funded at Boston University Medical Campus · NIH-11549671 · Data updated 2026-11-12

A short, patient-friendly look at how different lung macrophages influence tuberculosis outcomes and lesion growth at the infection site.

More Tuberculosis research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionBoston University Medical Campus
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 1, 2025
Project endJuly 31, 2027
Funding year2025
Award (this year)$210,887
NIH project number7R21AI188044-02
Project IDNIH-11549671 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals at risk for or affected by TB who could benefit from future lesion-targeted therapies or diagnostics.

Less likely to help

People not affected by TB or those without access to future lesion-focused treatments may not benefit.

What this research studies

This grant uses advanced single-cell methods to map how two macrophage types in the lung affect the growth and structure of TB lesions over time. It aims to connect cellular behavior with the real-world progression of tuberculosis in a living organism, bridging gaps between early mouse studies and human disease. The researchers will study macrophage metabolism and local environments inside necrotic lesions to understand how Mtb persists or is controlled. The goal is to uncover mechanisms that could lead to better treatments that target the lesion microenvironment. This work could ultimately help patients by informing therapies that improve lesion containment of TB.

Why it matters

Potential benefit: If successful, the findings could guide new approaches to limit Mtb growth within lung lesions and support the development of therapies targeting the lesion environment.

How similar studies have gone: Previous research in mice suggests macrophage types influence TB outcomes, but translating this to human disease remains a key area of exploration.

Where this research is happening

  • Boston University Medical Campus
    Boston, United States
    Active

Researchers

  • Principal investigator: Huang, Lu — Boston University Medical Campus
  • Study coordinator: Huang, Lu

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.